South Sudan has a high burden – among the highest in sub-Saharan Africa – of neglected tropical diseases (NTDs). This adversely affects the health and social and economic well-being of people in the country. The prevention, control and eventual elimination of many NTDs depend heavily on improved... access to water, sanitation and hygiene (WASH) and, once there is access, on sound sanitation and hygiene practices. This is especially the case in NTD endemic communities.
The main NTDs prevalent in South Sudan include lymphatic filariasis, schistosomiasis (bilharzia), soiltransmitted helminths (STH), onchocerciasis, trachoma, leishmaniasis and Guinea-worm disease.
While the Ministry of Health (MoH) of South Sudan, through its NTD programme, had prioritized NTD/WASH partnerships and collaboration to improve the national NTD response, the programme lacked resources, capacity and a technical framework to lead the development of a harmonized NTD/WASH communication strategy.
more
Un suivi et une évaluation efficaces sont nécessaires pour atteindre l’objectif d’élimination de la filariose lymphatique (FL). Après le traitement médicamenteux de masse (TMM) conformément aux lignes directrices élaborées par l’OMS, des programmes doivent être mis en œuvre afin de d...éterminer si les interventions ont permis de réduire la prévalence de l’infestation à un niveau en deçà duquel sa transmission ne pourra vraisemblablement pas perdurer. L’enquête d’évaluation
de la transmission (TAS) a été conçue de manière à offrir une structure simple et robuste afin de déterminer si la prévalence de la filariose lymphatique chez des enfants de 6–7 ans est inférieure à un seuil préalablement déterminé. Le TAS fournit aux administrateurs de programmes les informations factuelles nécessaires pour décider de l’opportunité d’arrêter le TMM. Le TAS garantit aux pouvoirs publics que les programmes nationaux ont atteint leur objectif d’élimination de la FL.
Ce guide a été conçu pour enseigner aux membres du personnel des programmes nationaux d’élimination de la FL, notamment le personnel de santé aux niveaux régional et de district, les éléments essentiels des programmes nationaux de suivi et d’évaluation pour l’élimination de la FL. Le guide est axé sur la planification et la mise en œuvre du TAS afin de pouvoir décider de l’opportunité
d’interrompre le TMM et de commencer la surveillance post-TMM.
more
A través de la investigación, la formación y la creación de sinergias con otros centros y organizaciones, buscamos dotar de mayor visibilidad y recursos la lucha contra esta enfermedad desatendida.
Le but de cette note de concept est donc de définir Ie rôle de I'APOC dans I'élimination de l'onchocercose, ainsi que sa contribution aux efforts visant à éliminer la filariose
Iymphatique et d'autres maladies tropicales négligées ciblées, et au renforcement des
systèmes de santé au nive...au communautaire. Avec un plan bien étudié, en collaboration avec d'autres partenaires, deux maladies majeures et associées faisant actuellement l'objet d'interventions - à savoir 1'onchocercose et Ia filaroise lymphatique - auront été éliminées dans au moins 23 pays d'ici l'année 2025.
more
The Strategic Plan of Action and Budget 2016-2025 for the elimination of onchocerciasisin countries was prepared based on the above dlrective for the consideration of IAF 18.The vision of the plan of action is to eliminate onchocerciasis in 80 percent of Africancountries. Implementation of the plan ...will also help strengthen health systems at community level while implementing CDI wlll help scale-up interventions agalnst other NTDs to the benefit of the wider national health systems.
more
Last accessed on 14.05.2023
Youtube - Video
Website last accessed on 14.05.2023
Youtube video
Website last accessed on 14.05.2023
Leishmaniasis A group of diseases, caused by the Leishmania parasites and transmitted by the sandfly
Vector-borne diseases are responsible for 17% of the global burden of communicable diseases and more than 500 000 deaths annually. The ambitious global targets for the control of vector-borne diseases come in the context of the (re-)emergence of diseases, increasing resistances to insecticides and u...ncertainty related to the financing of global vector control efforts. The United Nations 2030 Agenda with its related Sustainable Development Goals (SDGs), the New Urban Agenda adopted at the United Nations Conference on Housing and Sustainable Urban Development (Habitat III)
in Quito in 2016 and WHO’s Global vector control response 2017–2030 (WHO, 2017a) emphasize the value of elevating multisectoral actions and strategies that extend beyond the health sector to the core of integrated vector control.
This policy brief underlines the important role housing conditions have in the transmission of vector-borne diseases and showcases interventions and policies the housing sector can contribute to effective, integrated and intersectoral vector-borne diseases management.
more
Accessed on 14.05.2023
Building on the progress of the London Declaration on Neglected Tropical Diseases (NTDs) and putting individuals and communities at the centre of the NTD response, we, the signatories of this declaration, come together to commit to ending NTDs.
Esta publicación tiene como objetivo fundamental, presentar en lenguaje claro y objetivo, informaciones actualizadas sobre las formas de transmisión de la
enfermedad, sus vectores, su ciclo biológico y métodos de control. Su contenido
se dirige, principalmente, a los técnicos y profesionales ...brasileños que actúan en
el control y en la vigilancia de los vectores de la enfermedad de Chagas y por otro
lado, también a personas que no están familiarizadas con el tema. Entretanto, el
lenguaje simple y objetivo adoptado permite que la obra también pueda ser utilizada
por personas que no están familiarizadas con el asunto.
more
The Pandemic Influenza Pandemic (PIP) Framework's Partnership Contribution (PC) High-Level Implementation Plan III (HLIP III) outlines the strategy for strengthening global pandemic influenza preparedness from 2024 to 2030. HLIP III takes into consideration the lessons learned from the response to t...he COVID-19 pandemic, the gains made over time, including from previous HLIPs, and the broader programmatic and policy context in order to address gaps in pandemic influenza preparedness. Implementation of HLIP III will strengthen global, regional, and country-level pandemic influenza preparedness.
more
[Presentación] El presente libro, elaborado por integrantes de múltiples generaciones
de técnicos e investigadores salvadoreños dedicados a la enfermedad de Chagas, refleja claramente su actual situación epidemiológica, la evolución
histórica de la misma y los retos y perspectivas que la... prevención, control
y atención médica de la enfermedad de Chagas presentan al país.
También se destaca el aporte de la Agencia de Cooperación Internacional del Japón (JICA), que junto con OPS en Centroamérica y CIDA Canadá en Honduras, han ocupado un capítulo fundamental en el desarrollo de la vigilancia y control de la Enfermedad de
Chagas.
more
Website last accessed on 22.05.2023
The LEAP platform aims to strengthen clinical research capacity, which is lacking in part due to the remoteness and geographic spread of the patients, most of whom live in the most impoverished regions of Africa.
Website last accessed on 22.05.2023
Youtube Video:
Maureen Richards Immunology & Microbiology - Leishmania
Website last accessed on 22.05.2023
Youtube-Video
Leishmania- Ciclo de Vida
Leishmaniasis is a vector-borne tropical/subtropical disease caused by an intracellular parasite transmitted to humans by sand fly bite. It is endemic in Asia, Africa, the Americas, and the Mediterranean region. Worldwide reports include 1.5–2 million new cases each year, more than 300 million at ...risk of acquiring the disease, and 70,000 deaths per year. Clinical features depend on the Leishmania species and immune response of the host, varying from localized cutaneous disease to visceral form with potentially fatal outcome; however, the common presentation is either cutaneous, mucocutaneous, or visceral leishmaniasis. Many therapeutic agents are being used in Leishmania treatment, but the only effective treatment is achieved with current pentavalent antimonials. WHO considers Leishmaniasis as one of the “Neglected Tropical Diseases” that continues to be prevalent despite international, national, and local efforts towards its control and elimination over the last decade. This chapter reviews the global perspective of Leishmaniasis with increasing recognition of emerging “Atypical forms” and new surge of disease across the world mainly due to increasing conflicts in endemic areas leading to forced migration among other causes. All these challenges related to environment, disease, and vector pose major implications on WHO’s leishmaniasis control and elimination plan.
more
Website last accessed on 22.05.2023
Leishmaniasis refers to a diverse group of diseases caused by single-celled parasites called Leishmania. About 12 million people are infected at any one time, causing up to 40,000 deaths annually.
The VALIDATE Network - Vaccine development for complex intra...cellular neglected pathogens
more
The guidance in this publication consists of generic definitions and methodologies for the characterization of extreme weather and climate events. This publication contribute to ensuring consistent exchange of information that underpins the WMO State of the Climate Reports, Climate Watches, climate ...change studies and other emerging applications.
The purpose of the present guidelines is not to change the practice at the national level. Instead, it provides guidance for generic definitions, which are useful in contributing to WMO State of the Climate reports, climate watches, climate change studies and other emerging applications, including the recently adopted methodology for cataloguing hazardous events (WMO-CHE). These applications require regional and/or international exchange of information on extreme events.
more
Geneva, 22 May 2023 – Gavi, the Vaccine Alliance today published a roadmap* outlining critical actions needed to ensure supply of oral cholera vaccine (OCV) is able to meet growing demand from countries. Released against a backdrop of a recent wave of cholera outbreaks around the world, the roadma...p forecasts the short-, mid- and long-term outlook for global cholera vaccine supply. Developed in consultation with a range of key Alliance partners, including WHO, UNICEF, the Global Taskforce for Cholera Control (GTFCC), and the Bill and Melinda Gates Foundation (BMGF), it describes how these organizations, manufacturers and countries can work together towards ensuring global OCV supply can support largescale preventive vaccination by 2026.
more